The new guideline proposes a new way to classify AF, emphasizes the importance of early rhythm control and lifestyle modification, and gives catheter ablation a Class 1 indication.
Researchers conducted a clinical trial on the effects of dapagliflozin on the urinary albumin-to-creatinine ratio (UACR) in patients with heart failure (HF) and type 2 diabetes mellitus (T2D).
The new cardiovascular disease risk equations start at age 30, include measures of kidney and metabolic health, add heart failure, and remove race from the equations.